✦ LIBER ✦

Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis

✍ Scribed by V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. Antonelli; St. Bastianello; C. Pozzilli

Publisher: Springer
Year: 2005
Tongue: English
Weight: 261 KB
Volume: 253
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-005-0979-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-marketing survey on clinical respon

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

✍ C. Pozzilli; L. Prosperini; E. Sbardella; L. De Giglio; E. Onesti; V. Tomassini 📂 Article 📅 2005 🏛 Springer Milan 🌐 English ⚖ 76 KB

Predictive factors of neutralizing antib

Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

Spotlight on Multiple Sclerosis: From an

Spotlight on Multiple Sclerosis: From antibodies as a predictor to the clinical characteristics of responders to interferon therapy

✍ Michael Strupp 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 147 KB

The combination of cyclophosphamide plus

The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing–remitting multiple sclerosis patients

✍ E. Reggio; A. Nicoletti; T. Fiorilla; G. Politi; A. Reggio; F. Patti 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 256 KB

Matrix metalloproteinases and their tiss

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-β therapy in relapsing and secondary-progressive multiple sclerosis patients

✍ Yanina Galboiz; Sarah Shapiro; Nitza Lahat; Hannah Rawashdeh; Ariel Miller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 952 KB

Clinical significance of hepatic HCV RNA

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

✍ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-␣ (IFN-␣) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN